Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Experimental & Molecular Medicine ; : 509-518, 2006.
Article Dans Anglais | WPRIM | ID: wpr-69447

Résumé

Angiotensin II (Ang II), which is an important mediator of both vascular responsiveness and growth, has been shown to induce vascular smooth muscle cell (VSMC) hypertrophy via the activation of a complex series of intracellular signaling events. Heat shock protein 70 (Hsp70) has recently been shown to protect against Ang II-induced hypertension. In this study, we tested the hypothesis that Hsp70 can protect VSMC from Ang II-induced hypertrophy. We treated VSMCs with Ang II to induce hypertrophy and to activate MAPK signaling pathway. We observed that the augmentation of Hsp70 expression inhibited Ang II-stimulated VSMC hypertrophy. This inhibitory effect of Hsp70 appears to be partly due to extracellular signal-regulated kinase (ERK1/2) inactivation, which in turn, may possibly result from the accumulation of MAP kinase phosphatase-1 (MKP-1).


Sujets)
Rats , Mâle , Animaux , Rat Sprague-Dawley , Petit ARN interférent/pharmacologie , Protein Tyrosine Phosphatases/métabolisme , Phosphoprotein Phosphatases/métabolisme , Muscles lisses vasculaires/cytologie , Mitogen-Activated Protein Kinase 3/antagonistes et inhibiteurs , Mitogen-Activated Protein Kinase 1/antagonistes et inhibiteurs , MAP Kinase Kinase 2/métabolisme , MAP Kinase Kinase 1/métabolisme , Protéines précoces immédiates/métabolisme , Hypertrophie , Protéines du choc thermique HSP70/antagonistes et inhibiteurs , Flavonoïdes/pharmacologie , Stabilité enzymatique/effets des médicaments et des substances chimiques , Cellules cultivées , Protéines du cycle cellulaire/métabolisme , Aorte/effets des médicaments et des substances chimiques , Angiotensine-II/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche